Observational studyCNS drugs2020

Changes in Anti-JCV Antibody Status in a Large Population of Multiple Sclerosis Patients Treated with Natalizumab.

Eleonora Sgarlata et al.PubMed ↗Publisher ↗

No numbers read from the abstract.